News | December 04, 2014

Pocket ECG Technology Supports AF Research for Texas Cardiac Arrhythmia Research Foundation

Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project, investigating the impact of lifestyle modification on ablation outcome in atrial fibrillation (ISOLATE)

December 4, 2014 — Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project, investigating the impact of lifestyle modification on ablation outcome in atrial fibrillation (ISOLATE). The research is financed by Texas Cardiac Arrhythmia Research Foundation. The PocketECG cardiac monitoring system will be used for collecting and analyzing the ECG data in the project.

This prospective randomized pilot study will evaluate the impact of aggressive lifestyle modification, in terms of calorie?controlled diet and supervised exercise, on outcomes of catheter ablation in overweight and obese patients with atrial fibrillation. The principal investigators are Andrea Natale, M.D. with Texas Cardiac Arrhythmia Research Foundation and Mitra Mohanty, M.D., with The University of Texas at Austin.

The hypothesis states that weight loss and management by adoption of a strict diet and exercise regimen improves the chances of freedom from recurrence following catheter ablation.

One important aspect of the project is the role of autonomic neural imbalance in arrhythmogenesis. Weight?loss and aerobic exercise are believed to reverse the autonomic remodeling and enhance the electrical stability of the heart.

The trial will help to evaluate the impact of weight?loss and exercise on HRV during rest and physical activity in the intervention and no?intervention cohort.

The study’s eligible group is overweight or obese adult patients with a diagnosis of atrial fibrillation undergoing first catheter ablation at least 3 months after the enrollment.

Supervised and monitored exercise will be conducted in St. David's Cardiac Rehabilitation for at least three months before ablation. After ablation, patients will continue an individualized home?exercise program for 1 year.

For more information: clinicaltrials.gov

Related Content

OTC ECG devices

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Feature | ECG | March 11, 2020
Apple created a stir when it...
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. Bittium Faros Holter monitoring.

The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. 
 

News | ECG | January 22, 2020
January 22, 2020 – Bittium is exhibiting solutions for cardiology at...
Cardiologs
News | ECG | December 12, 2019
December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI)
FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...